Karalliedde, Janaka <br/><br/>
Effect of renin-angiotensin system blockade on soluble Klotho in patients with type 2 diabetes, systolic hypertension, and albuminuria.  [electronic resource] 

 -  Clinical journal of the American Society of Nephrology : CJASN  Nov 2013 
 - 1899-905 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1555-905X 
<br/><br/><label>Standard No.: </label>10.2215/CJN.02700313  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Albuminuria--blood<br/>Amlodipine--therapeutic use<br/>Angiotensin II Type 1 Receptor Blockers--therapeutic use<br/>Biomarkers--blood<br/>Blood Pressure--drug effects<br/>Calcium Channel Blockers--therapeutic use<br/>Diabetes Mellitus, Type 2--blood<br/>Diabetic Nephropathies--blood<br/>Diuretics--therapeutic use<br/>Female<br/>Glucuronidase--blood<br/>Hospitals, University<br/>Humans<br/>Hydrochlorothiazide--therapeutic use<br/>Hypertension--blood<br/>Klotho Proteins<br/>London<br/>Male<br/>Middle Aged<br/>Phosphates--blood<br/>Pulse Wave Analysis<br/>Renin-Angiotensin System--drug effects<br/>Systole<br/>Tetrazoles--therapeutic use<br/>Time Factors<br/>Treatment Outcome<br/>Valine--analogs & derivatives<br/>Valsartan